Skip to main content
Initiator Pharma A/S logo

Initiator Pharma A/S — Investor Relations & Filings

Ticker · INIT ISIN · DK0060775872 LEI · 213800DFI4I1A5RVKB59 ST Professional, scientific and technical activities
Open in API
Filings indexed 3 across all filing types
Latest filing 2022-06-15 Share Issue/Capital Cha…
Country DK Denmark
Listing ST INIT

About Initiator Pharma A/S

https://www.initiatorpharma.com/

Initiator Pharma A/S is a clinical-stage life science company that develops innovative drugs for unmet medical needs related to the central and peripheral nervous system. The company's core technology focuses on the therapeutic modulation of monoamine neurotransmitters, utilizing unique monoamine reuptake inhibitors to target specific diseases. Its development pipeline includes several projects in both clinical and preclinical stages. The lead programs target erectile dysfunction, particularly for patients who are non-responsive to current therapies, and vulvodynia, a debilitating condition with no approved treatments.

Recent filings

Filing Released Lang Actions
Approval of prospectus for Initiator Pharma A/S; Shares
Share Issue/Capital Change Classification · 95% confidence The document is a formal 'EU Growth Prospectus' for a 'Preferential Rights Issue' by Initiator Pharma A/S. It contains detailed information regarding the offer, risk factors, business overview, and financial information, and was approved by the Danish Financial Supervisory Authority. While prospectuses are often associated with capital raising, they are distinct from simple announcements. In the provided taxonomy, 'Capital/Financing Update' (CAP) is the most appropriate category for documents detailing rights issues and share offerings.
2022-06-15 English
Godkendelse af prospekt for Initiator Pharma A/S , Aktier, 08.07.2021
Capital/Financing Update Classification · 100% confidence The document is an 'EU Growth Prospectus' for a 'Preferential Rights Issue' by Initiator Pharma A/S. It contains detailed information regarding the offer, terms and conditions, risk factors, and financial information incorporated by reference. This document is a formal capital raising document (prospectus) used for securities offerings, which falls under the 'Capital/Financing Update' category.
2021-07-08 English
Godkendelse af lille prospekt for Initiator Pharma A/S , 25.01.2017
Capital/Financing Update Classification · 95% confidence The document is a formal 'Prospekt' (Prospectus) for Initiator Pharma A/S, detailing a new share issue ('Nyemission') in connection with a planned listing on the AktieTorget exchange. It contains comprehensive sections on risk factors, company description, financial overview, and terms of the offering. While it relates to a capital raise, the document itself is a full prospectus, which is a primary offering document. In the provided taxonomy, 'CAP' (Capital/Financing Update) is the most appropriate category for documents detailing share issuance and fundraising activities.
2017-01-25 Danish

Browse filings by year

3 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.